LEXARIA BIOSCIENCE CORP. Debt Instrument, Convertible, Conversion Price
LEXARIA BIOSCIENCE CORP. (LEXX) had Debt Instrument, Convertible, Conversion Price of $0.15 per share as of 2017-08-25, per its 10-K filed 2018-11-14.
Discontinued › Notes
us-gaap:DebtInstrumentConvertibleConversionPrice1 · last filed 2018-11-14
- 2017-08-25: Debt Instrument, Convertible, Conversion Price $0.15.
| Period end | Debt Instrument, Convertible, Conversion Price |
|---|---|
| 2017-08-25 | $0.15 10-K · filed 2018-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |